SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM) today announced that Kathleen M. Wiltsey has been elected to the Company’s board of directors. “Kathleen brings significant biotechnology commercialization experience to Sequenom and we plan to call upon her experience in launching and marketing two leading biotechnology products as we expand our core business product offerings and prepare to introduce a revolutionary portfolio of non-invasive prenatal diagnostics. We are pleased to welcome Kathleen to the board,” said Harry F. Hixson, Jr., Chairman of the Company’s board of directors.
